| Microglia morphology and proinflammatory signaling in the nucleus accumbens during nicotine withdrawal A Adeluyi, L Guerin, ML Fisher, A Galloway, RD Cole, SSL Chan, ... Science advances 5 (10), eaax7031, 2019 | 76 | 2019 |
| Dopamine triggers CTCF-dependent morphological and genomic remodeling of astrocytes A Galloway, A Adeluyi, B O'Donovan, ML Fisher, CN Rao, P Critchfield, ... Journal of Neuroscience 38 (21), 4846-4858, 2018 | 37 | 2018 |
| Altered gating of Kv1.4 in the nucleus accumbens suppresses motivation for reward B O'Donovan, A Adeluyi, EL Anderson, RD Cole, JR Turner, PI Ortinski Elife 8, e47870, 2019 | 13 | 2019 |
| Glial cells as therapeutic targets for smoking cessation M Kumar, A Adeluyi, EL Anderson, JR Turner Neuropharmacology 175, 108157, 2020 | 8 | 2020 |
| Increased prevalence of indoor Aspergillus and Penicillium species is associated with indoor flooding and coastal proximity: a case study of 28 moldy buildings MH Omebeyinje, A Adeluyi, C Mitra, P Chakraborty, GM Gandee, N Patel, ... Environmental Science: Processes & Impacts 23 (11), 1681-1687, 2021 | 7 | 2021 |
| Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiency G Murlidharan, J Brown, E KNOLL, Y Shu, K BALES, J Hou, A ADELUYI, ... US Patent App. 18/018,017, 2023 | | 2023 |
| Efficacy evaluation of a novel vectorized anti‐tau antibody, targeting a C‐terminal phospho‐tau epitope, using systemic dosing of a blood brain barrier penetrant AAV capsid in … W Liu, M Paranjpe, J Holth, B Clarke, J Thompson, J Clement, E Knoll, ... Alzheimer's & Dementia 18, e062924, 2022 | | 2022 |
| Identification and characterization of novel anti-tau antibodies that inhibit tau-seed mediated pathology in a P301S tauopathy mouse model Alzheimer’s Disease and tauopathies L Wencheng, P Maneesha, B Clarke, A Adeluyi AAIC 2022, 2022 | | 2022 |
| Efficacy of a Novel Vectorized Antibody Targeting the C-Terminal Domain of Tau, Antibody 1, using Systemic Dosing of a Blood Brain Barrier Penetrant AAV Capsid in Mouse Models … W Liu, M Paranjpe, J Holth, B Clarke, J Thomson, J Clement, E Knoll, ... MOLECULAR THERAPY 30 (4), 483-483, 2022 | | 2022 |
| Development of AAV-GBA1 Gene Replacement Therapy for IV Delivery via Blood Brain Barrier Penetrant AAV Capsid C Chung, G Murlidharan, S Jagtap, A Adeluyi, E Knoll, A Ecker, B Ezell, ... MOLECULAR THERAPY 30 (4), 268-268, 2022 | | 2022 |
| Development of CNS-directed GBA1 gene replacement therapy for IV delivery via Blood Brain Barrier Penetrant AAV Capsid G Murlidharan, S Jagtap, A Adeluyi, E Knoll, A Ecker, B Ezell, ... HUMAN GENE THERAPY 32 (19-20), A53-A54, 2021 | | 2021 |
| Identifying Neural Correlates of Nicotine Withdrawal in Mice: The Neuregulin Signaling Pathway M Fisher, B O'Donovan, A Adeluyi, P Ortinski, J Turner The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| Glia Responsivity in Nicotine Dependence AO Adeluyi University of South Carolina, 2019 | | 2019 |
